The burgeoning popularity of semaglutide , initially for diabetes , is creating significant attention within the United Kingdom , prompting a notable shift in medication trends. Access these compounds remains a complex challenge , with public healthcare system approval currently limited and specialist practices offering therapy at a premium . Conce